Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA drug recalls in 2015

Every FDA drug recall initiated in 2015, newest first, with its risk class, status and the reason the FDA recorded. Use the cause and risk filters to narrow the year down.

1,733 recalls, newest first.

Class II · Moderate risk

WellPatch¿ Capsaicin Pain Relief Patch

Labeling: Incorrect Instructions; The word not is missing from the following sentences "do bandage tightly or cover with any type of wrap except clothing and "do use with a heating pad or with other heat sources in the Drug Facts panel "Warning" section

Terminated Labeling / mix-up The Mentholatum Co. NDC 10742-8126-2 D-0018-2016
Class III · Low risk

UN1002 Air

CGMP Deviations: Confirmed customer compliant of odor when turning on a cylinder of medical air.

Terminated cGMP deviation Praxair Inc. D-0783-2016
Class III · Low risk

UN1002 Air

CGMP Deviations: Confirmed customer compliant of odor when turning on a cylinder of medical air.

Terminated cGMP deviation Praxair Inc. D-0782-2016
Class II · Moderate risk

Zinc Sulfate

Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

Terminated Sterility / contamination US Compounding Inc NDC 62295-3226-07 D-0294-2016
Class II · Moderate risk

Voriconazole Solution

Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

Terminated Sterility / contamination US Compounding Inc NDC 62295-2815-10 D-0293-2016
Class II · Moderate risk

Vitamin D3 in Olive Oil

Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

Terminated Sterility / contamination US Compounding Inc NDC 62295-3277-06 D-0292-2016
Class II · Moderate risk

Vancomycin Ophthalmic PF 0.5 mL

Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

Terminated Sterility / contamination US Compounding Inc NDC 62295-0209-64 D-0291-2016
Class II · Moderate risk

Tropicamide 1%/Phenylephrine 2.5%

Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

Terminated Sterility / contamination US Compounding Inc NDC 62295-3214-07 D-0290-2016
Class II · Moderate risk

Tropicamide 0.5%/ Phenylephrine 5%

Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

Terminated Sterility / contamination US Compounding Inc NDC 62295-3298-02 D-0289-2016
Class II · Moderate risk

Tri-Mix 30/1/10

Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

Terminated Sterility / contamination US Compounding Inc NDC 62295-3256-05 D-0288-2016
Class II · Moderate risk

Triamcinolone diacetate USP PF

Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

Terminated Sterility / contamination US Compounding Inc NDC 62295-3206-01 D-0287-2016
Class II · Moderate risk

Triamcinolone diacetate USP

Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

Terminated Sterility / contamination US Compounding Inc NDC 62295-3205-06 D-0286-2016
Class II · Moderate risk

Triamcinolone/Lidocaine

Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

Terminated Sterility / contamination US Compounding Inc NDC 62295-3204-07 D-0285-2016
Class II · Moderate risk

Triamcinolone acetonide

Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

Terminated Sterility / contamination US Compounding Inc NDC 62295-3203-07 D-0284-2016
Class II · Moderate risk

Trace Elements-4

Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

Terminated Sterility / contamination US Compounding Inc NDC 62295-3201-07 D-0283-2016
Class II · Moderate risk

Testosterone EO-Pro-Cyp 220

Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

Terminated Sterility / contamination US Compounding Inc NDC 62295-2169-06 D-0282-2016
Class II · Moderate risk

Testosterone cypionate

Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

Terminated Sterility / contamination US Compounding Inc NDC 62295-2131-07 D-0281-2016
Class II · Moderate risk

Succinylcholine Chloride

Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

Terminated Sterility / contamination US Compounding Inc NDC 62295-3292-07 D-0280-2016
Class II · Moderate risk

Pilocarpine

Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

Terminated Sterility / contamination US Compounding Inc D-0278-2016
Class II · Moderate risk

Phenylephrine PF Sterile Solution

Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

Terminated Sterility / contamination US Compounding Inc NDC 62295-3272-03 D-0277-2016
Class II · Moderate risk

Phenylephrine PF

Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

Terminated Sterility / contamination US Compounding Inc NDC 62295-3159-07 D-0276-2016
Class II · Moderate risk

Phenylephrine

Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

Terminated Sterility / contamination US Compounding Inc NDC 62295-3289-05 D-0275-2016
Class II · Moderate risk

Phenylephrine 10% PF Ophthalmic Solution

Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

Terminated Sterility / contamination US Compounding Inc NDC 62295-3273-03 D-0274-2016
Class II · Moderate risk

Phenylephrine 1.5%/ Lidocaine 1%

Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

Terminated Sterility / contamination US Compounding Inc NDC 62295-3155-01 D-0273-2016

Recalls by year